NASDAQ:AHCO AdaptHealth Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding AdaptHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $22.63 -0.25 (-1.09 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range$22.47Now: $22.63▼$24.2150-Day Range$19.48MA: $21.96▼$25.3352-Week Range$7.82Now: $22.63▼$25.93Volume3.71 million shsAverage Volume204,498 shsMarket Capitalization$1.91 billionP/E Ratio75.43Dividend YieldN/ABeta-0.03 ProfileAnalyst RatingsChartCompetitorsEarningsInstitutional OwnershipHeadlinesShort InterestSocial Media AdaptHealth, LLC distributes home medical equipment. The Company offers mobility products, respiratory therapy, non- invasive ventilation, nutrition supplies, ocean home health products, sleep therapy supplies, bed lifts, seat lift chairs, and bath aids. AdaptHealth, LLC was founded in 2012 and is based in Phoenixville, Pennsylvania.Read More Beat the Market (BTM) Rank™ 1.5 Analyst's Opinion Consensus RatingAdaptHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $24.33, AdaptHealth has a forecasted upside of 7.5% from its current price of $22.63.Amount of Analyst CoverageAdaptHealth has only been the subject of 3 research reports in the past 90 days. Previous Next 3.2 Community Rank Outperform VotesAdaptHealth has received 28 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAdaptHealth has received 16 “underperform” votes. (Add your “underperform” vote.)Community SentimentAdaptHealth has received 63.64% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about AdaptHealth and other stocks. Vote “Outperform” if you believe AHCO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AHCO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAdaptHealth does not currently pay a dividend.Dividend GrowthAdaptHealth does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AdaptHealth insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 10.89% of the stock of AdaptHealth is held by insiders.Percentage Held by InstitutionsOnly 12.36% of the stock of AdaptHealth is held by institutions. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for AdaptHealth are expected to grow by 46.81% in the coming year, from $0.47 to $0.69 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AdaptHealth is 75.43, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.68.Price to Earnings Ratio vs. SectorThe P/E ratio of AdaptHealth is 75.43, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 25.80. Previous Next Analyst Opinion: 1.5Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.32 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Home health care services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AHCO Previous Symbol CUSIPN/A CIKN/A Webwww.adapthealth.com Phone610-630-6357Debt Debt-to-Equity RatioN/A Current Ratio1.03 Quick Ratio0.93Price-To-Earnings Trailing P/E Ratio75.43 Forward P/E Ratio48.15 P/E GrowthN/A Sales & Book Value Annual Sales$529.64 million Price / Sales3.60 Cash Flow$1.84 per share Price / Cash Flow12.29 Book Value($0.73) per share Price / Book-31.00Profitability EPS (Most Recent Fiscal Year)$0.30 Net Income$-15,000,000.00 Net MarginsN/A Return on Equity-42.67% Return on Assets1.17%Miscellaneous Employees2,590 Outstanding Shares84,313,000Market Cap$1.91 billion Next Earnings Date11/3/2020 (Estimated) OptionableNot Optionable $22.63 -0.25 (-1.09 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive AHCO News and Ratings via Email Sign-up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter. AdaptHealth (NASDAQ:AHCO) Frequently Asked Questions How has AdaptHealth's stock price been impacted by COVID-19 (Coronavirus)? AdaptHealth's stock was trading at $15.82 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AHCO shares have increased by 43.0% and is now trading at $22.63. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of AdaptHealth? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for AdaptHealth. When is AdaptHealth's next earnings date? AdaptHealth is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020. View our earnings forecast for AdaptHealth. How were AdaptHealth's earnings last quarter? AdaptHealth Corp. (NASDAQ:AHCO) issued its earnings results on Tuesday, August, 4th. The company reported $0.08 EPS for the quarter, missing the Zacks' consensus estimate of $0.11 by $0.03. The firm earned $232.12 million during the quarter, compared to analyst estimates of $195.36 million. View AdaptHealth's earnings history. What guidance has AdaptHealth issued on next quarter's earnings? AdaptHealth updated its FY 2020 Pre-Market earnings guidance on Tuesday, August, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $935-983 million, compared to the consensus revenue estimate of $888.77 million. What price target have analysts set for AHCO? 6 brokers have issued twelve-month target prices for AdaptHealth's stock. Their forecasts range from $15.00 to $33.00. On average, they expect AdaptHealth's stock price to reach $24.33 in the next year. This suggests a possible upside of 7.5% from the stock's current price. View analysts' price targets for AdaptHealth. Are investors shorting AdaptHealth? AdaptHealth saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,130,000 shares, an increase of 106.9% from the August 15th total of 546,200 shares. Based on an average daily volume of 335,400 shares, the days-to-cover ratio is currently 3.4 days. Currently, 4.1% of the company's shares are sold short. View AdaptHealth's Short Interest. Who are some of AdaptHealth's key competitors? Some companies that are related to AdaptHealth include Amedisys (AMED), LHC Group (LHCG), Option Care Health (OPCH), Addus Homecare (ADUS), Cancer Treatment (CTHZ) and New York Health Care (BBAL). View all competitors. What other stocks do shareholders of AdaptHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other AdaptHealth investors own include Advanced Micro Devices (AMD), Walt Disney (DIS), Johnson & Johnson (JNJ), American International Group (AIG), Aphria (APHA), Biogen (BIIB), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Cigna (CI) and salesforce.com (CRM). Who are AdaptHealth's key executives? AdaptHealth's management team includes the following people: Mr. Luke McGee, CEO & Director (Age 36)Mr. Joshua Parnes, Pres & Director (Age 41)Mr. Gregg A. Holst, Chief Financial Officer (Age 60)Mr. Christopher J. Joyce, Gen. Counsel (Age 55)Mr. Shaw Rietkerk, Chief Revenue Officer (Age 44) What is AdaptHealth's stock symbol? AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO." Who are AdaptHealth's major shareholders? AdaptHealth's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Deerfield Management Company L.P. Series C (1.66%), Bank of New York Mellon Corp (1.28%), Silvercrest Asset Management Group LLC (0.87%), FMR LLC (0.70%), Driehaus Capital Management LLC (0.70%) and RMB Capital Management LLC (0.29%). Which major investors are selling AdaptHealth stock? AHCO stock was sold by a variety of institutional investors in the last quarter, including Deerfield Management Company L.P. Series C, and Bank of America Corp DE. Which major investors are buying AdaptHealth stock? AHCO stock was acquired by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Silvercrest Asset Management Group LLC, FMR LLC, Driehaus Capital Management LLC, Beryl Capital Management LLC, Jabodon PT Co., Charles Schwab Investment Management Inc., and RMB Capital Management LLC. How do I buy shares of AdaptHealth? Shares of AHCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is AdaptHealth's stock price today? One share of AHCO stock can currently be purchased for approximately $22.63. How big of a company is AdaptHealth? AdaptHealth has a market capitalization of $1.91 billion and generates $529.64 million in revenue each year. The company earns $-15,000,000.00 in net income (profit) each year or $0.30 on an earnings per share basis. AdaptHealth employs 2,590 workers across the globe. What is AdaptHealth's official website? The official website for AdaptHealth is www.adapthealth.com. How can I contact AdaptHealth? AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The company can be reached via phone at 610-630-6357 or via email at [email protected] This page was last updated on 9/19/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
